• Allen Brain Atlas Reveals Data from First Two Scanned Brains

    Forbes | The Allen Brain Atlas published its first results yesterday in Nature, and some were surprising. Gene expression on the right and left sides of the brain looks very similar, but the variety that is there seems to be pretty important.

    Sep 21, 2012

  • MyoKardia Gains Venture Funds to Investigate Drugs for Genetic Heart Defects

    Xconomy | Third Rock Ventures is investing $38 million in a startup that is targeting the genetic causes of heart problems. MyoKardia will set up shop in San Francisco.

    Sep 21, 2012

  • Google Ventures has $1 Billion to Spend, Eyes Biotech

    CNBC | Google Ventures is planning $1 billion of start-up investment in the next five years and it has its eye on biotech.

    Sep 21, 2012

  • Novartis Takes $665m Bid for Selexys

    Tulsa World | In addition to $23 million of Series A financing, Selexys Pharmaceuticals Corp. of Oklahoma City has struck an agreement with Novartis that could lead to the company's acquisition for up to $665 million for its sickle cell treatment.

    Sep 21, 2012

  • Microfluidics, NGS, and Personalized Cosmetics

    Bio-IT World Video | Bio-IT World Editor Kevin Davies speaks with Dave Weitz, professor of physics at Harvard and speaker at the upcoming Consumer Genomics Conference, about his research on microfluidics, which has applications in everything from next-gen sequencing technology to personalized cosmetics.

    Sep 21, 2012

  • Foundation Medicine Announces $42.5m in Series B Financing

    Boston Globe |  Foundation Medicine announced a $42.5 million Series B financing round this morning thanks to Deerfield Management Company, L.P., Casdin Capital, Redmile Group and strategic investors Roche Venture Fund and WuXi Corporate Venture Fund.

    Sep 20, 2012

  • New Pharma Collaboration Focuses on Clinical Standards

    Bio-IT World | A new big pharma collaboration has been launched to identify and solve common drug development challenges, starting with clinical study execution. TransCelerate BioPharma was created by ten companies—Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech (a member of the Roche Group), and Sanofi—all of which have pooled financial, personnel, and other resources to solve industry-wide challenges in a collaborative environment. 

    Sep 19, 2012

  • Illumina Acquires Cytogenetics Company BlueGnome

    BlueGnome | Illumina today announced that it will acquire UK company BlueGnome, a cytogenetics company that looks at the structure and function of cells for genetic abnormalities. 

    Sep 19, 2012

  • The Genomics Guinea Pigs

    NPR | The researchers who are serving as genomics guinea pigs are also working through how we should process the information the genome reveals.

    Sep 19, 2012

  • Genomic Applications for All

    23andMe | 23andMe has released their API to allow developers to design new applications and tools for the 23andMe community accessing 23andMe data.

    Sep 18, 2012

  • Firms Charge Fiduciary Breach in BGI-Complete Merger

    Bio-IT World | The announcement on Monday that Complete Genomics will be acquired by BGI for $117.6 million has left many surprised and dismayed. A slew of firms have announced investigations of the Complete Genomics Board of Directors contending that the $3.15/share price may not be "fair". 

    Sep 18, 2012

  • Biotech Making Friends with Twitter

    Xconomy | Biotech comes into its own on Twitter. Luke Timmerman of Xconomy discusses the advantages for the industry.

    Sep 18, 2012

  • Craigslist Helps Reveal Flu Antibody

    UT San Diego | Researchers from the Scripps Research Institute in La Jolla and Sea Lane Biotechnologies have identified an antibody that protects cells from the influenza virus with the help of Craigslist donors.

    Sep 17, 2012

  • Pharma Turns to Second Generation Emerging Markets

    GlobalData | Sanofi is looking past the BRIC countries--Brazil, Russia, India, China--at other emerging markets, singling out Columbia, Indonesia, and Vietnam for future growth. 

    Sep 17, 2012

  • Sequencing Giants BGI and Complete Genomics Announce Merger Agreement

    Bio-IT World | In a stunning move for the genomics industry, two leading DNA sequencing service providers – China’s BGI and Complete Genomics – have entered into a definitive merger agreement valued at $117 million.  

    Sep 17, 2012

  • Panasas Launches Combo Flash Storage

    Bio-IT World | Panasas today announced an update to its parallel storage system: ActiveStor 14, the first product in the industry to use flash memory and an intelligent storage layout for mixed workloads, Geoffrey Noer, senior director of product marketing, tells Bio-IT World.  

    Sep 14, 2012

  • Supercomputing the Resistome

    TACC | Nobel laureate Bruce Beutler is using the supercomputing resources at  the Texas Advanced Computing Center (TACC) at The University of Texas at Austin to sequence the exomes of 8,000 mice in order to identify the mammalian "resistome".

    Sep 14, 2012

  • PerkinElmer Acquires R&D Rights to TIBCO Software

    Boston Globe | PerkinElmer has acquired exclusive rights to TIBCO Software's data analysis software in scientific research and development markets. 

    Sep 14, 2012

  • Sequencing Studies Take on Lung Cancer

    Nature News | Three sequencing studies published this week take on lung cancer, laying the groundwork for more effective personalized treatment. The studies looked at a combined 361 patients with different types of lung cancers and an additional 17 tumors.

    Sep 14, 2012

  • Boehringer Ingelheim Launches Pharma Facebook Game

    PSFK | Boehringer Ingelheim has developed a Facebook game called Syrum. The health of the world is in the user's hands, and players can collaborate with others to save it.

    Sep 13, 2012